尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Koopman Brian, 首席财务官. Officer active across 1 company, notably Utah Medical Products INC. In total, 6 filings have been recorded. History available since 27 October 2021. The latest transaction was filed on 4 September 2025 (Don). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Brian Koopman is Directeur Financier and Principal Financial Officer at Utah Medical Products INC, listed on XNAS. He has 6 filings in total, and the 6 sampled filings, from 2021-10-28 to 2025-09-05, show Don transactions with individual amounts of EUR 37185.3564865193, EUR 35522.86390925266, EUR 5807.23099153303, EUR 5169.584043958444, EUR 3284.392448636076 and EUR 2691.535740348649.